1.            Tal, M., Minert, A. & Devor, M. Resurgent neuropathic discharge: An obstacle to the therapeutic use of neuroma resection? Pain 164, 349–361 (2023).

2.            Sharav, Y., Haviv, Y. & Tal, M. Placebo or Nocebo Interventions as Affected by Hypnotic Susceptibility. Appl. Sci. 13, (2023).

3.            Gitik, M., Elberg, G., Reichert, F., Tal, M. & Rotshenker, S. Deletion of CD47 from Schwann cells and macrophages hastens myelin disruption/dismantling and scavenging in Schwann cells and augments myelin debris phagocytosis in macrophages. J. Neuroinflammation 20, (2023).

4.            Garcia-Monaco, R., Naif, A., Tal, M. G. & Trerotola, S. The Global Reading Room: Treating a Fibrin Sheath. Am. J. Roentgenol. 221, 277–278 (2023).

5.            Tal, M. G. & Yevzlin, A. S. Catheter-related blood stream infection in hemodialysis patients with symmetric tunneled non-side-hole hemodialysis catheters. J. Vasc. Access 24, 614–619 (2023).

6.            Tal, M. G. et al. Pressure-Induced Fibroid Ischemia: First-In-Human Experience with a Novel Device for Laparoscopic Treatment of Symptomatic Uterine Fibroids. Reprod. Sci. 30, 1366–1375 (2023).

7.            Tal, M. G. & Yevzlin, A. S. Staphylococcus aureus accumulation at the tip of hemodialysis catheters with or without tip side holes in catheter related bloodstream infection in a large animal. J. Vasc. Access 24, 232–237 (2023).

8.            Tal, M. G., Covey, A., Qaqish, S., Livne, R. & Klass, D. Prospective evaluation of efficacy and safety of distal radial and radial artery access using a novel articulating-tip guidewire. J. Vasc. Access (2023) doi:10.1177/11297298231212227.

9.            Tal, M. G., Reeves, M. F., Hathaway, M. J., Canela, J. M. & Katz, B. A proposed classification for intrauterine device position:the Tal-Reeves classification. BMJ Sex. Reprod. Heal. 48, 157–159 (2022).

10.          Avrahami, M. et al. Inframalleolar access in endovenous treatment of venous ulcers and C5 disease with nonthermal nontumescent techniques. J. Vasc. Surg. Venous Lymphat. Disord. 10, 417–422 (2022).

11.          Tal, M. G. & Yevzlin, A. S. Initial Clinical Experience with a Symmetric Tip Tunneled Hemodialysis Catheter Without Side Holes. ASAIO J. 67, 1257–1262 (2021).

12.          Rizzitelli, S. et al. Reduced nontarget embolization and increased targeted delivery with a reflux-control microcatheter in a swine model. Diagn. Interv. Imaging 102, 641–648 (2021).

13.          Elberg, G. et al. Deletion of SIRPα (signal regulatory protein-α) promotes phagocytic clearance of myelin debris in Wallerian degeneration, axon regeneration, and recovery from nerve injury. J. Neuroinflammation 16, (2019).

14.          Ziv, N. Y., Tal, M. & Shavit, Y. The transition from naïve to primed nociceptive state: A novel wind-up protocol in mice. Exp. Neurol. 275, 133–142 (2016).

15.          Devor, M. & Tal, M. Nerve resection for the treatment of chronic neuropathic pain. Pain 155, 1053–1054 (2014).

16.          Nitzan-Luques, A., Minert, A., Devor, M. & Tal, M. Dynamic genotype-selective ‘phenotypic switching’ of CGRP expression contributes to differential neuropathic pain phenotype. Exp. Neurol. 250, 194–204 (2013).

17.          Ringkamp, M. et al. Local loperamide injection reduces mechanosensitivity of rat cutaneous, nociceptive C-fibers. PLoS One 7, (2012).

18.          Nitzan-Luques, A., Devor, M. & Tal, M. Genotype-selective phenotypic switch in primary afferent neurons contributes to neuropathic pain. Pain 152, 2413–2426 (2011).

19.          Gabay, E., Wolf, G., Shavit, Y., Yirmiya, R. & Tal, M. Chronic blockade of interleukin-1 (IL-1) prevents and attenuates neuropathic pain behavior and spontaneous ectopic neuronal activity following nerve injury. Eur. J. Pain 15, 242–248 (2011).

20.          Nissenbaum, J. et al. Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res. 20, 1180–1190 (2010).

21.          Eliav, E., Benoliel, R., Herzberg, U., Kalladka, M. & Tal, M. The role of IL-6 and IL-1β in painful perineural inflammatory neuritis. Brain. Behav. Immun. 23, 474–484 (2009).

22.          Kaufmann, D. et al. Evaluation of the enantioselective antiallodynic and pharmacokinetic profile of propylisopropylacetamide, a chiral isomer of valproic acid amide. Neuropharmacology 54, 699–707 (2008).

23.          Kleibeuker, W. et al. IL-1β signaling is required for mechanical allodynia induced by nerve injury and for the ensuing reduction in spinal cord neuronal GRK2. Brain. Behav. Immun. 22, 200–208 (2008).

24.          Tal, M. & Devor, M. Anatomy and neurophysiology of orofacial pain. in Orofacial Pain and Headache 19–44 (Elsevier, 2008). doi:10.1016/B978-0-7234-3412-2.10002-1.

25.          Sharav, Y. & Tal, M. Response to Editorial on Sharav and Tal (2006). Pain 127, 195 (2007).

26.          Benoliel, R., Tal, M. & Eliav, E. Effects of Topiramate on the Chronic Constriction Injury Model in the Rat. J. Pain 7, 878–883 (2006).

27.          Sharav, Y. & Tal, M. Focused hypnotic analgesia: Local and remote effects. Pain 124, 280–286 (2006).

28.          Wolf, G., Gabay, E., Tal, M., Yirmiya, R. & Shavit, Y. Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice. Pain 120, 315–324 (2006).

29.          Tal, M. & Sharav, Y. Jaw clenching modulates sensory perception in high- but not in low-hypnotizable subjects. J. Orofac. Pain 19, 76–81 (2005).

30.          Eliav, E., Tal, M. & Benoliel, R. Experimental malignancy in the rat induces early hypersensitivity indicative of neuritis. Pain 110, 727–737 (2004).

31.          Gabay, E. & Tal, M. Pain behavior and nerve electrophysiology in the CCI model of neuropathic pain. Pain 110, 354–360 (2004).

32.          Cherkas, P. S. et al. The effects of axotomy on neurons and satellite glial cells in mouse trigeminal ganglion. Pain 110, 290–298 (2004).

33.          Benoliel, R., Sharav, Y., Tal, M. & Eliav, E. Management of chronic orofacial pain: today and tomorrow. Compend. Contin. Educ. Dent. 24, 909–920, 922–924, 926-928 passim; quiz 932 (2003).

34.          Zubare-Samuelov, M. et al. Some sweet and bitter tastants stimulate inhibitory pathway of adenylyl cyclase via melatonin and α2-adrenergic receptors in Xenopus laevis melanophores. Am. J. Physiol. - Cell Physiol. 285, C1255–C1262 (2003).

35.          Eliav, E. et al. Facial arthralgia and myalgia: Can they be differentiated by trigeminal sensory assessment? Pain 104, 481–490 (2003).

36.          Weick, M. et al. P2 receptors in satellite glial cells in trigeminal ganglia of mice. Neuroscience 120, 969–977 (2003).

37.          Benoliel, R., Wilensky, A., Tal, M. & Eliav, E. Application of a pro-inflammatory agent to the orbital portion of the rat infraorbital nerve induces changes indicative of ongoing trigeminal pain. Pain 99, 567–578 (2002).

38.          Guo, W. et al. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. J. Neurosci. 22, 6208–6217 (2002).

39.          Benoliel, R., Eliav, E. & Tal, M. Strain-dependent modification of neuropathic pain behaviour in the rat hindpaw by a priming painful trigeminal nerve injury. Pain 97, 203–212 (2002).

40.          Eliav, E., Benoliel, R. & Tal, M. Inflammation with no axonal damage of the rat saphenous nerve trunk induces ectopic discharge and mechanosensitivity in myelinated axons. Neurosci. Lett. 311, 49–52 (2001).

41.          Benoliel, R., Eliav, E. & Tal, M. No sympathetic nerve sprouting in rat trigeminal ganglion following painful and non-painful infraorbital nerve neuropathy. Neurosci. Lett. 297, 151–154 (2001).

42.          Levy, D., Tal, M., Höke, A. & Zochodne, D. W. Transient action of the endothelial constitutive nitric oxide synthase (ecNOS) mediates the development of thermal hypersensitivity following peripheral nerve injury. Eur. J. Neurosci. 12, 2323–2332 (2000).

43.          Tal, M., Wall, P. D. & Devor, M. Myelinated afferent fiber types that become spontaneously active and mechanosensitive following nerve transection in the rat. Brain Res. 824, 218–223 (1999).

44.          Naim, M., Striem, B. J. & Tal, M. Cellular Signal Transduction of Sweetener-Induced Taste. Advances in Food and Nutrition Research vol. 42 211–243 (1998).

45.          Tal, M. & Liberman, R. Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci. Lett. 221, 129–132 (1997).

46.          Tal, M. & Eliav, E. Abnormal discharge originates at the site of nerve injury in experimental constriction neuropathy (CCI) in the rat. Pain 64, 511–518 (1996).

47.          Tal, M. A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy. Neuroreport 7, 1382–1384 (1996).

48.          Ben-Aharon, U. et al. Amplification of protooncogenes and expression of the HER2/NEU oncogene in invasive breast cancer. Harefuah 130, 4–8 (1996).

49.          Tal, M. et al. A Novel Putative Neuropeptide Receptor Expressed in Neural Tissue, Including Sensory Epithelia. Biochem. Biophys. Res. Commun. 209, 752–759 (1995).

50.          Sharav, Y. & Tal, M. Hypnotic analgesia and reflex activity. Pain 63, 391 (1995).

51.          Tal, M. & Bennett, G. J. Extra-territorial pain in rats with a peripheral mononeuropathy: mechano-hyperalgesia and mechano-allodynia in the territory of an uninjured nerve. Pain 57, 375–382 (1994).

52.          Tal, M. & Bennett, G. J. Neuropathic pain sensations are differentially sensitive to dextrorphan. Neuroreport 5, 1438–1440 (1994).

53.          Lev-Tov, A., Tal, M. & Lavy, R. Diverse firing properties of single motor units in the inner and outer portions of the guinea pig anterior digastric muscle. Arch. Oral Biol. 38, 169–178 (1993).

54.          Tal, M. & Devor, M. Ectopic discharge in injured nerves: comparison of trigeminal and somatic afferent. Brain Res. 579, 148–151 (1992).

55.          YAFFE, A., TAL, M. & EHRLICH, J. Effect of occlusal bite‐raising splint on electromyogram, motor unit histochemistry and myoneuronal dimensions in rats. J. Oral Rehabil. 18, 343–351 (1991).

56.          Tal, M. & Sharav, Y. Masseter inhibitory periods and sensations upon electrical tooth-pulp stimulation in children and adults. Brain Res. 497, 138–141 (1989).

57.          Sharav, Y. & Tal, M. Masseter inhibitory periods and sensations evoked by electrical tooth-pulp stimulation in subjects under hypnotic anesthesia. Brain Res. 479, 247–254 (1989).

58.          Seltzer, Z., Tal, M. & Sharav, Y. Autotomy behavior in rats following peripheral deafferentation is suppressed by daily injections of amitriptyline, diazepam and saline. Pain 37, 245–250 (1989).

59.          Tal, M. Neural basis for initiation of rhythmic digastric activity upon midbrain stimulation in the guinea pig. Brain Res. 411, 58–64 (1987).

60.          Lev-Tov, A. & Tal, M. The organization and activity patterns of the anterior and posterior heads of the guinea pig digastric muscle. J. Neurophysiol. 58, 496–509 (1987).

61.          Rotshenker, S., Ring, G., Tal, M., Sugarman, H. & Reichert, F. Regulation of motor axon sprouting. Isr. J. Med. Sci. 23, 89–94 (1987).

62.          Tal, M. & Sharav, Y. Development of sensory and reflex responses to tooth-pulp stimulation in children. Arch. Oral Biol. 30, 467–470 (1985).

63.          Tal, M. The threshold for eliciting the jaw opening reflex in rats is not increased by neonatal capsaicin. Behav. Brain Res. 13, 197–200 (1984).

64.          RAJSTEIN, J. & TAL, M. The effect of ultrasonic scaling on the surface of Class V amalgam restorations—a scanning electron microscopy study. J. Oral Rehabil. 11, 299–305 (1984).

65.          Irving, S. G. et al. Isolation and characterization of a novel retrovirus from sheep affected by pulmonary carcinoma. Virology 134, 244–248 (1984).

66.          Tal, M. & Rotshenker, S. Sprouting and synapse formation produced by carbocaine. J. Neurosci. 4, 458–463 (1984).

67.          Tal, M. & Rotshenker, S. Recycling of synaptic vesicles in motor nerve endings separated from their target muscle fibers. Brain Res. 270, 131–133 (1983).

68.          Tal, M. The effect of a long-acting local anaesthetic agent (Marcaine®) on the masticatory muscle in rats. Int. J. Oral Surg. 11, 101–105 (1982).

69.          Tal, M., Sharav, Y. & Devor, M. Modulation of the jaw-opening reflex by peripheral electrical stimulation. Exp. Neurol. 74, 907–919 (1981).

70.          Tal, M. & Goldberg, L. J. Masticatory muscle activity during rhythmic jaw movements in the anaesthetized guinea-pig. Arch. Oral Biol. 26, 803–807 (1981).

71.          Laufer, B. et al. Fluoride-uptake and fluoride-residual of fluoride-treated human root dentine in vitro determined by chemical, scanning electron microscopy and X-ray diffraction analyses. Arch. Oral Biol. 26, 159–163 (1981).

72.          Tal, M. Representation of some masticatory muscles in the trigeminal motor nucleus of the guinea pig: Horseradish peroxidase study. Exp. Neurol. 70, 726–730 (1980).

73.          RAJSTEIN, J. & TAL, M. A study of the contour and external surface of Class V composite resin fillings. J. Oral Rehabil. 6, 21–25 (1979).

74.          TAL, M., KAUFMAN, A. Y. & BUCHNER, A. Bone necrosis and dentine resorption caused by Toxavit: a case report. Int. Endod. J. 11, 77–79 (1978).

75.          Kaufman, A. Y., Binderman, I., Tal, M., Gedalia, I. & Peretz, G. New chemotherapeutic agent for root canal treatment. A preliminary electron microscopic study on an in vivo and in vitro endodontically treated tooth. Oral Surgery, Oral Med. Oral Pathol. 46, 283–295 (1978).

76.          Tal, M., Oron, M., Gedalia, I. & Ehrlich, J. X-ray diffraction and scanning electron microscope investigations of fluoride-treated dentine in man. Arch. Oral Biol. 21, 285–290 (1976).

77.          Ehrlich, J., Hochman, N., Gedalia, I. & Tal, M. Residual Fluoride Concentrations and Scanning Electron Microscopic Examination of Root Surfaces of Human Teeth After Topical Application of Fluoride In Vivo. J. Dent. Res. 54, 897–900 (1975).